JNJ

227.3

-0.24%↓

ISRG

507.91

-2.78%↓

ABT

106.03

+0.05%↑

MDT

100.97

+0.31%↑

133.13

-0.58%↓

JNJ

227.3

-0.24%↓

ISRG

507.91

-2.78%↓

ABT

106.03

+0.05%↑

MDT

100.97

+0.31%↑

133.13

-0.58%↓

JNJ

227.3

-0.24%↓

ISRG

507.91

-2.78%↓

ABT

106.03

+0.05%↑

MDT

100.97

+0.31%↑

133.13

-0.58%↓

JNJ

227.3

-0.24%↓

ISRG

507.91

-2.78%↓

ABT

106.03

+0.05%↑

MDT

100.97

+0.31%↑

133.13

-0.58%↓

JNJ

227.3

-0.24%↓

ISRG

507.91

-2.78%↓

ABT

106.03

+0.05%↑

MDT

100.97

+0.31%↑

133.13

-0.58%↓

Strona główna・Stock List・Altimmune Inc

Altimmune Inc

Closed

5.11

Buy Sell

Overview

Share price change

24h

Current

Min

5.02

Max

5.47

Key metrics
By Trading Economics
Income	3.1M -19M
Sales	5K
Profit margin	-380,280
Employees	59
EBITDA	4.4M -18M

Recommendations
By TipRanks
Recommendations	Strong Buy
12 Months Forecast	+199.41% upside

Dividends
By Dow Jones
Next Earnings	26 mar 2026

Market Stats
By TradingEconomics
Market Cap	241M 591M
Previous open	5.11
Previous close	5.11

Technical Score

By Trading Central

Confidence

Bullish Evidence

5.365 / 6.0486 Support & Resistance

Altimmune Inc Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

29 sty 2026, 22:31 UTC

Earnings

KLA Posts Higher 2Q Profit On Product and Services Sales Growth

29 sty 2026, 22:05 UTC

Earnings

Stryker Logs Higher 4Q Profit On Sales Gains

29 sty 2026, 21:54 UTC

Earnings

Visa 1Q Sales Climb on Strong Holiday Shopping -- Update

29 sty 2026, 21:36 UTC

Earnings

Visa 1Q Sales Climb on Strong Holiday Shopping

29 sty 2026, 23:57 UTC

Acquisitions, Mergers, Takeovers

Aluminum Corp. of China: to Hold 67% of Joint Venture With Rio Tinto

29 sty 2026, 23:56 UTC

Acquisitions, Mergers, Takeovers

Aluminum Corp. of China: Deal Valued at Roughly BRL4.69 Billion

29 sty 2026, 23:53 UTC

Acquisitions, Mergers, Takeovers

Aluminum Corp. of China Says It, Rio Tinto Propose to Buy 69% Stake in Companhia Brasileira de Aluminio S.A.

29 sty 2026, 23:51 UTC

Earnings

Correction to Intel Earnings Article on Jan. 22 -- WSJ

29 sty 2026, 23:49 UTC

Market Talk

Nikkei May Decline After Wall Street Tech Selloffs -- Market Talk

29 sty 2026, 23:49 UTC

Market Talk

Gold Rises Amid Ongoing Iran Tensions -- Market Talk

29 sty 2026, 23:47 UTC

Market Talk

Pro Medicus Looks Attractive Ahead of 1H Result -- Market Talk

29 sty 2026, 23:35 UTC

Earnings

Apple Posts Blowout iPhone Sales on Surging China Demand -- 2nd Update

29 sty 2026, 23:32 UTC

Market Talk

REA's 1H Result Could Jolt Share Price More Than Usual -- Market Talk

29 sty 2026, 23:32 UTC

Market Talk

Global Equities Roundup: Market Talk

29 sty 2026, 23:15 UTC

Market Talk

Earnings

Visa Says High Earners Still Lead Spending Growth -- Market Talk

29 sty 2026, 22:27 UTC

Earnings

Sandisk Beats Earnings. The Stock Is Soaring. -- Barrons.com

29 sty 2026, 22:27 UTC

Earnings

GE Vernova Gains After Earnings. Guidance Boost Was Enough to Lift the Stock. -- Barrons.com

29 sty 2026, 22:12 UTC

Earnings

Visa Beats Expectations on Stronger Spending. The Stock Is Falling. -- Barrons.com

29 sty 2026, 21:55 UTC

Earnings

Micron Stock Rises. Samsung Signals a 'Golden Era' for Memory Chips. -- Barrons.com

29 sty 2026, 21:50 UTC

Market Talk

Earnings

Financial Services Roundup: Market Talk

29 sty 2026, 21:50 UTC

Earnings

These Stocks Are Today's Movers: Microsoft, Meta, Tesla, Joby Aviation, SAP, Royal Caribbean, and More -- Barrons.com

29 sty 2026, 21:50 UTC

Market Talk

Earnings

Health Care Roundup: Market Talk

29 sty 2026, 21:50 UTC

Market Talk

Earnings

Auto & Transport Roundup: Market Talk

29 sty 2026, 21:49 UTC

Earnings

Honeywell Delivers Solid Earnings Ahead of Its Corporate Breakup -- Barrons.com

29 sty 2026, 21:46 UTC

Earnings

Apple Posts Blowout iPhone Sales on Surging China Demand -- Update

29 sty 2026, 21:36 UTC

Earnings

Lockheed Martin Stock Jumps on Guidance and Government Missile Deal -- Barrons.com

29 sty 2026, 21:32 UTC

Earnings

Visa Beats Expectations on Stronger Spending. The Stock Is Falling. -- Barrons.com

29 sty 2026, 21:32 UTC

Earnings

Sandisk Beats Earnings. The Stock Is Soaring. -- Barrons.com

29 sty 2026, 21:30 UTC

Earnings

Apple Posts Blowout IPhone Sales on Surging China Demand -- WSJ

29 sty 2026, 21:30 UTC

Earnings

Apple 1Q Mac Rev $8.39B >AAPL

Peer Comparison

Price change

Altimmune Inc Forecast

Price Target

By TipRanks

199.41% upside

12 Months Forecast

Average 15.33 USD 199.41%

High 20 USD

Low 12 USD

Based on 5 Wall Street analysts offering 12 month price targets forAltimmune Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

5 ratings

Buy

Hold

Sell

Based on 5 analysts giving stock ratings to Altimmune Inc - Dist in the past 3 months.

Technical Score

By Trading Central

5.365 / 6.0486Support & Resistance

Recent bullish events outweigh bearish events.

All events are bearish.

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

About Altimmune Inc

Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity and liver diseases. The company's lead product candidate, pemvidutide, a GLP-1/glucagon dual receptor agonist that is in Phase 2 trial for the treatment of obesity and metabolic dysfunction-associated steatohepatitis. It is also developing HepTcell, an immunotherapeutic product candidate, which is in Phase 2 clinical trial for patients chronically infected with the hepatitis B virus. The company was formerly known as Vaxin Inc. and changed its name to Altimmune, Inc. in September 2015. Altimmune, Inc. was founded in 1997 is headquartered in Gaithersburg, Maryland.